Treatment of chronic cerebral dysfunction by dsRNA methodology

Details Treatment of chronic cerebral dysfunction by dsRNA methodology Treatment of chronic cerebral dysfunction by dsRNA methodology

1992-06-15

1993-11-02

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 49, 514 50, A01N 4304

Patent

active

052583694

ABSTRACT:
Patients having chronic fatigue syndrome having chronic cerebral dysfunction, as characterized by memory lapses occasional seizures and loss of cognitive functions are treated with a dsRNA such as rI.multidot.r(C.sub.11-14,U) to improve the patient's clinical condition.

Affiliated with

Also associated with

Rating

Treatment of chronic cerebral dysfunction by dsRNA methodology does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of chronic cerebral dysfunction by dsRNA methodology, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of chronic cerebral dysfunction by dsRNA methodology will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1757534